CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 151 filers reported holding CONMED CORP in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $47,502,704 | -10.5% | 685,126 | +3.4% | 0.00% | -20.0% |
Q1 2024 | $53,080,419 | -24.8% | 662,741 | +2.9% | 0.01% | -28.6% |
Q4 2023 | $70,568,135 | +14.1% | 644,321 | +5.0% | 0.01% | 0.0% |
Q3 2023 | $61,869,144 | -22.7% | 613,397 | +4.2% | 0.01% | -22.2% |
Q2 2023 | $79,990,877 | +39.2% | 588,644 | +6.4% | 0.01% | +28.6% |
Q1 2023 | $57,453,207 | +121972.0% | 553,179 | +4.2% | 0.01% | 0.0% |
Q4 2022 | $47,065 | -99.9% | 530,972 | +3.6% | 0.01% | +16.7% |
Q3 2022 | $41,104,000 | -11.7% | 512,711 | +5.5% | 0.01% | -14.3% |
Q2 2022 | $46,531,000 | -36.5% | 485,923 | -1.4% | 0.01% | -22.2% |
Q1 2022 | $73,231,000 | +8.1% | 492,976 | +3.2% | 0.01% | +12.5% |
Q4 2021 | $67,744,000 | +11.3% | 477,883 | +2.7% | 0.01% | 0.0% |
Q3 2021 | $60,873,000 | -6.5% | 465,285 | -1.8% | 0.01% | -11.1% |
Q2 2021 | $65,091,000 | +12.8% | 473,634 | +7.2% | 0.01% | 0.0% |
Q1 2021 | $57,700,000 | +25.9% | 441,841 | +8.0% | 0.01% | +12.5% |
Q4 2020 | $45,834,000 | +52.0% | 409,233 | +6.8% | 0.01% | +33.3% |
Q3 2020 | $30,156,000 | +6.1% | 383,341 | -2.9% | 0.01% | 0.0% |
Q2 2020 | $28,429,000 | +28.6% | 394,917 | +2.3% | 0.01% | 0.0% |
Q1 2020 | $22,098,000 | -74.1% | 385,863 | -49.5% | 0.01% | -33.3% |
Q4 2019 | $85,380,000 | +136.5% | 763,492 | +103.4% | 0.01% | +12.5% |
Q3 2019 | $36,099,000 | +13.1% | 375,450 | +0.7% | 0.01% | 0.0% |
Q2 2019 | $31,906,000 | +16.0% | 372,866 | +12.7% | 0.01% | +14.3% |
Q1 2019 | $27,513,000 | -27.8% | 330,771 | -44.3% | 0.01% | +16.7% |
Q4 2018 | $38,104,000 | +76.9% | 593,532 | +118.3% | 0.01% | 0.0% |
Q3 2018 | $21,535,000 | +12.6% | 271,846 | +4.0% | 0.01% | 0.0% |
Q2 2018 | $19,128,000 | +27.5% | 261,318 | +10.3% | 0.01% | +20.0% |
Q1 2018 | $14,999,000 | +27.2% | 236,846 | +2.3% | 0.01% | +25.0% |
Q4 2017 | $11,795,000 | -1.9% | 231,425 | +1.0% | 0.00% | 0.0% |
Q3 2017 | $12,027,000 | +5.3% | 229,219 | +2.2% | 0.00% | 0.0% |
Q2 2017 | $11,423,000 | +21.6% | 224,258 | +6.0% | 0.00% | 0.0% |
Q1 2017 | $9,394,000 | +9.8% | 211,542 | +9.2% | 0.00% | 0.0% |
Q4 2016 | $8,556,000 | +14.0% | 193,708 | +3.4% | 0.00% | 0.0% |
Q3 2016 | $7,502,000 | -14.5% | 187,286 | +1.8% | 0.00% | -20.0% |
Q2 2016 | $8,777,000 | +15.4% | 183,900 | +1.4% | 0.01% | +25.0% |
Q1 2016 | $7,603,000 | -2.9% | 181,300 | +2.0% | 0.00% | 0.0% |
Q4 2015 | $7,830,000 | -8.3% | 177,778 | -0.6% | 0.00% | -20.0% |
Q3 2015 | $8,538,000 | -15.9% | 178,862 | +2.6% | 0.01% | -16.7% |
Q2 2015 | $10,153,000 | +19.9% | 174,249 | +3.9% | 0.01% | +20.0% |
Q1 2015 | $8,469,000 | +22.6% | 167,749 | +9.2% | 0.01% | +25.0% |
Q4 2014 | $6,907,000 | +23.6% | 153,645 | +1.3% | 0.00% | 0.0% |
Q3 2014 | $5,588,000 | -12.4% | 151,693 | +5.0% | 0.00% | 0.0% |
Q2 2014 | $6,377,000 | -3.0% | 144,447 | -4.6% | 0.00% | 0.0% |
Q1 2014 | $6,575,000 | +4.3% | 151,345 | +2.1% | 0.00% | 0.0% |
Q4 2013 | $6,301,000 | +25.0% | 148,277 | -0.0% | 0.00% | 0.0% |
Q3 2013 | $5,040,000 | +10.0% | 148,289 | +1.1% | 0.00% | 0.0% |
Q2 2013 | $4,583,000 | – | 146,711 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |